跳至主要内容
临床试验/NCT04386018
NCT04386018
招募中
不适用

A Registered Cohort Study on Natural Course and Drug Efficacy of Inflammatory Demyelination Disease

Ning Wang, MD., PhD.1 个研究点 分布在 1 个国家目标入组 400 人2020年5月15日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Demyelinating Autoimmune Diseases, CNS
发起方
Ning Wang, MD., PhD.
入组人数
400
试验地点
1
主要终点
The correlation between clinical phenotypes and Serum antibodies
状态
招募中
最后更新
5年前

概览

简要总结

This study will provide further insights into the natural course of Inflammatory demyelination disease including clinical features,progression, related antibody spectrum and drug treatment effect

注册库
clinicaltrials.gov
开始日期
2020年5月15日
结束日期
2025年4月1日
最后更新
5年前
研究类型
Observational
性别
All

研究者

发起方
Ning Wang, MD., PhD.
责任方
Sponsor Investigator
主要研究者

Ning Wang, MD., PhD.

Director

First Affiliated Hospital of Fujian Medical University

入排标准

入选标准

  • Outpatient or inpatient
  • Meet the diagnostic criteria of Inflammatory Demyelination Disease.
  • Voluntary participation and informed consent signed by the applicant or his/her family.

排除标准

  • Severe complications
  • Poor prognosis (\<1 year survival)
  • Severe mental disorder and inability to cooperate with the examination.

结局指标

主要结局

The correlation between clinical phenotypes and Serum antibodies

时间窗: from date of enrollment until the date of death from any cause,assessed up to 20 years

Different clinical subtypes of Demyelinating Autoimmune Diseases have different course and prognosis.It may be related to different serum antibodies.

研究点 (1)

Loading locations...

相似试验